Fingerprint
Dive into the research topics of 'Vandetanib plus chemotherapy for induction followed by vandetanib or placebo as maintenance for patients with advanced non-small-cell lung cancer: A randomized phase 2 PrECOG study (PrE0501)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically